Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Tauopathy is a group of disorders characterized by the accumulation of hyperphosphorylated tau protein in the brain, resulting in dementia. 20544828 2010
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 GeneticVariation group BEFREE The range of tau pathology identified in FTDP-17 recapitulates that in sporadic tauopathies, indicating a major role for tau dysfunction in these diseases. 17493040 2007
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Imbalance of neuronal proteostasis associated with misfolding and aggregation of Tau protein is a common neurodegenerative feature in Alzheimer's disease (AD) and other Tauopathies. 30442948 2019
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE This could be a central aetiological mechanism in FTDP-17 and, perhaps, other related tauopathies. 12787326 2003
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE The tauopathies are a group of disorders characterised by aggregation of the microtubule-associated protein tau and include Alzheimer's disease (AD) and the fronto-temporal dementias (FTD). 14993907 2004
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 GeneticVariation group BEFREE MAPT p.R406W carriers present clinically with progressive memory loss and neuropathologically with neuronal and glial tauopathy. 30546007 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Progressive accumulation of highly phosphorylated tau protein isoforms is the main feature of a group of neurodegenerative diseases collectively called tauopathies. 29106033 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Mitochondrial dysfunction and oxidative stress play an important role in ageing and have been implicated in several age-related neurodegenerative conditions including Alzheimer's disease (AD) and other tauopathies characterized by the presence of intracellular accumulations of the hyperphosphorylated microtubule-associated protein tau. 19942317 2011
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 AlteredExpression group BEFREE Animal models of neurodegeneration induced by neuronal expression of truncated tau protein emerge as an important tool for understanding the pathogenesis of human tauopathies and for therapy development. 28527208 2017
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Despite the advent of novel therapeutic approaches and the increasing number of clinical trials in tauopathies, accurate clinical diagnosis is still an unmet need and better tau biomarkers are still desperately needed. 28914736 2017
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Hence, targeting hyperphosphorylated tau protein has now been considered as a valid therapeutic approach for these neurodegenerative tauopathies. 24880087 2014
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Tauopathies are subclassified according to the predominant species of tau that accumulates, with respect to alternative splicing of MAPT, with tau proteins containing three (3R) or four repeats (4R) of ~32 amino acids in the microtubule binding domain. 21720721 2011
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE The tauopathies are characterized by abnormal deposition of microtubule associated protein tau into intracellular neurofibrillary tangles composed mainly of the hyperphosphorylated form of the protein. 28453489 2017
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 GeneticVariation group BEFREE Thus, alterations in the amount of the tau protein, missense mutations, posttranscriptional modifications like phosphorylation, aberrant tau aggregation or a different expression of some of its isoforms could provoke pathological effects resulting in the appearance of neuronal disorders known as tauopathies. 17604998 2007
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Aggregation of the microtubule-associated protein, tau, can lead to neurofibrillary tangle formation in neurons and glia which is the hallmark of tauopathy. 30980950 2019
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE The formation of intraneuronal fibrillar inclusions of tau protein is associated with several neurodegenerative diseases referred to as tauopathies including Alzheimer's disease (AD). 30386294 2018
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Microtubule-associated protein tau is the major component of the filamentous neurofibrillary lesions of Alzheimer's disease (AD) and other tauopathies. 15918074 2005
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Since in Alzheimer's disease and related tauopathies tau proteostasis is compromised, here we sought to understand the role of tau protein in neuronal circadian biology and related behavior. 31824299 2019
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE The microtubule-associated protein tau, in a hyperphosphorylated form, aggregates into insoluble paired-helical filaments (PHFs) in Alzheimer's disease (AD) and other tauopathies. 19459590 2009
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 GeneticVariation group BEFREE This study demonstrates that cells actively release Tau in the absence of disease or toxicity, and Tau release is modified by changes in the Tau protein that are associated with tauopathies. 23105105 2012
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Tau pathology is also observed in frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) and other related diseases, so called tauopathies. 19967412 2010
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE We have extensively analyzed the biochemical and histochemical profiles of the tau protein from the rTg4510 transgenic mouse model in which the animals uniquely develop forebrain tau pathologies similar to those found in human tauopathies. 19074615 2009
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Aggregation of tau proteins is a distinct hallmark of tauopathies and has been a focus of research and clinical trials for Alzheimer's Disease. 30917861 2019
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 Biomarker group BEFREE Pathological tau protein inclusions have long been recognized to define the diverse range of neurodegenerative disorders called the tauopathies, which include Alzheimer's disease (AD), progressive supranuclear palsy (PSP) and frontotemporal lobar degeneration. 16987883 2006
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.600 AlteredExpression group BEFREE A keystone in the diagnosis of tauopathies was the development of methods to assess levels of tau protein in vivo in cerebrospinal fluid, which has significantly improved our knowledge about these conditions. 30529601 2019